A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine

NCT03137927 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation